Pancreatic Cancer Research

ResearcherVA Greater Los Angeles Healthcare SystemNo recent work listed

Kazuki Takakura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1444-3761; OpenAlex author ID A5062795615. Sources: OpenAlex.

Their work

Papers
16 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 3 papers · 2015: 3 papers · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 16

  1. STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancr… Co-author DOI 10.1016/j.eclinm.2022.101731↗
  2. The Diverse Involvement of Cigarette Smoking in Pancreatic Cancer Development and Prognosis. First author DOI 10.1097/mpa.0000000000001550↗
  3. The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer. Co-author DOI 10.3390/ijms20133331↗
  4. Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms. First author DOI 10.5306/wjco.v10.i2.67↗
  5. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2018.8961↗
  6. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges. Co-author DOI 10.1152/ajpgi.00138.2017↗
  7. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. Co-author DOI 10.1371/journal.pone.0184455↗
  8. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. First author DOI 10.3892/ol.2017.6071↗
  9. Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour sit… Co-author DOI 10.3109/00365521.2015.1121515↗
  10. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model. Co-author DOI 10.1371/journal.pone.0142981↗
  11. Direct therapeutic intervention for advanced pancreatic cancer. Co-author DOI 10.5306/wjco.v6.i6.216↗
  12. Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for p… Co-author PMID 25550602↗
  13. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0314↗
  14. Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. Co-author DOI 10.1179/1973947813y.0000000150↗
  15. Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer. Co-author DOI 10.4161/21624011.2014.958950↗
  16. Clinical usefulness of diffusion-weighted MR imaging for detection of pancreatic cancer: comparison with enhanced multidetector-row CT. Co-author DOI 10.1007/s00261-011-9728-7↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigeo Koido · 9 shared papers, 2014–2019 · strength 0.49
  2. Masayuki Saruta · 4 shared papers, 2018–2020 · strength 0.44
  3. Mikio Kajihara · 7 shared papers, 2014–2018 · strength 0.33
  4. Naohisa Yahagi · 2 shared papers, 2019–2023 · strength 0.27
  5. Zensho Ito · 5 shared papers, 2015–2018 · strength 0.26
  6. Yuichi Torisu · 2 shared papers, 2019 · strength 0.23
  7. Masato Okamoto · 5 shared papers, 2014–2018 · strength 0.23
  8. Stephen Jacob Pandol · 2 shared papers, 2017–2020 · strength 0.20
  9. Guido Eibl · 2 shared papers, 2017–2020 · strength 0.20
  10. Haruo Sugiyama · 4 shared papers, 2014–2018 · strength 0.18
  11. Hisao Tajiri · 5 shared papers, 2011–2015 · strength 0.18
  12. Tomoya Kanai · 3 shared papers, 2016–2018 · strength 0.18
  13. Sadamu Homma · 4 shared papers, 2014–2015 · strength 0.16
  14. Toshio Fujisawa · 1 shared paper, 2023 · strength 0.16
  15. Makoto Nishimura · 1 shared paper, 2023 · strength 0.16
  16. Yoko Matsuda · 1 shared paper, 2023 · strength 0.16
  17. Hiroyuki Isayama · 1 shared paper, 2023 · strength 0.16
  18. Motohiko Kato · 1 shared paper, 2023 · strength 0.16
  19. Tomio Arai · 1 shared paper, 2023 · strength 0.16
  20. Shomei Ryozawa · 1 shared paper, 2023 · strength 0.16
  21. Takao Itoi · 1 shared paper, 2023 · strength 0.16
  22. Hideyuki Saya · 1 shared paper, 2023 · strength 0.16
  23. Simcha I Weissman · 1 shared paper, 2020 · strength 0.15
  24. Shuichi Fujioka · 2 shared papers, 2017–2018 · strength 0.13
  25. Anna S. Gukovskaya · 2 shared papers, 2017 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.